Zantac® (ranitidine hydrochloride)

Home » Zantac

ATTENTION ZANTAC USERS!

Did you or a loved one take Zantac regularly to treat heartburn and were diagnosed with:

  • Bladder Cancer
  • Kidney Cancer
  • Colon Cancer
  • Rectal Cancer
  • Stomach Cancer
  • Other Cancers

You May Be Eligible To File A Claim.

DO NOT STOP TAKING MEDICATION WITHOUT CONSULTING YOUR DOCTOR.

FREE CASE REVIEW

  • This field is for validation purposes and should be left unchanged.

Your Zantac® Lawsuit

The attorneys at Olinde Law are representing Zantac users who have developed certain types of cancer. You may be able to take legal action against the pharmaceutical manufacturing company. With thousands of people now stricken with cancer after taking Zantac, many are turning to the courts to file a Zantac lawsuit and hold Sanofi and Boehringer Ingelheim accountable for their actions.

The U.S. Food and Drug Administration (FDA) Zantac investigations discovered a cancer risk for the Zantac 150 tablets that contains a carcinogenic chemical up to 3,000 times greater than the FDA’s daily intake limit.  The carcinogenic chemical present in Zantac is known as N-nitrosodimethylamine (“NDMA”).

Many studies have demonstrated the relationship between the NDMA in Zantac and cancer. Mounting evidence indicates that Sanofi and Boehringer Ingelheim (the maker Zantac (ranitidine hydrochloride), may have known there was a Zantac cancer connection. The public who took the drug Zantac for heartburn, gastric and duodenal ulcers, gastroesophageal reflux disease (GERD), sour stomach, Barrett’s esophagus, acid reflux and other issues may now be at risk.

We Are Here To Help You

If you or a loved one were diagnosed with Cancer after taking Zantac, call Olinde Law Firm for a free and confidential consultation.  Zantac has associated with the following types of cancers:

  • Bladder Cancer
  • Kidney Cancer
  • Colon Cancer
  • Rectal Cancer
  • Stomach Cancer
  • Intestinal Cancer
  • Leukemia
  • Liver Cancer
  • Pancreatic Cancer
  • Lymphoma
  • Myeloma
  • Prostate Cancer

Our law firm is here to fight for justice and the compensation you may deserve.  These large and powerful pharmaceutical companies can be challenging. We have a track record of winning cases against these large companies and corporations, and we are here to help.

What is Zantac®?

Zantac(ranitidine hydrochloride) is a very popular antacid medication that has been on the market since the early 1980s. Zantac is available over the counter (Zantac OTC) and by prescription. The most common uses for Zantac are the following:

  • acid reflux
  • heartburn
  • stomach issues
  • throat issues
  • gastrointestinal issues.

 

Zantac dosage varies between 75 and 150 mg tablets, though some patients take a once-daily Zantac 300 mg dosage.

 

ZANTAC IS A REGISTERED TRADEMARK OF SANOFI CONSUMER HEALTHCARE.

DO NOT STOP TAKING MEDICATION WITHOUT CONSULTING YOUR DOCTOR

Common Zantac® Brands | Products That Contain Ranitidine

Below are some of the most common Zantac brands and generic ranitidine brand names:

  • Zantac 150 Tablets
  • Zantac 150 Maximum Strength
  • Zantac 150 Maximum Strength Cool Mint
  • Zantac 75 Tablets
  • Wal-Zan 150
  • Wal-Zan 75
  • Heartburn Relief (ranitidine)
  • Acid Reducer (ranitidine)
  • Acid Control (ranitidine)

Does Zantac® Cause Cancer?

The World Health Organization (WHO) classifies the chemical N-nitrosodimethylamine (NDMA) as a cancer-causing carcinogen. Zantac and its generic active ingredient, ranitidine hcl, metabolizes into NDMA.

According to the EPA, N-nitrosamines are “a family of potent carcinogens.” NDMA is a semi-volatile organic chemical that belongs to a family of chemicals known as N-nitrosamines.

The FDA established a 96 ng (nanograms) per day intake limit of NDMA. However, recent testing of Zantac using FDA-approved methods found more than 2,500,000 ng of NDMA in a Zantac 150 mg tablet which is a common dosage that people take every day.

Zantac® Recall

In response to the September 2019 FDA announcement, the following retailers pulled Zantac from their shelves:

  • CVS
  • Walgreens

They cited that the reason for the product pull was from the link between Zantac NDMA and cancer. In statements, both pharmacy companies noted that consumers who purchased the drugs could get Zantac refunds.

In October 2019, Sanofi and Boehringer Ingelheim announced a Zantac recall of its own in the United States and Canada, and the U.K. unit of Teva Pharmaceuticals, the largest generic drug maker in the world, recalled batches of ranitidine.

NDMA and Zantac® Cancer Risk

During the development process of rocket fuel, the NDMA molecule was discovered. The chemical is created with the combination of DMA and Nitrogen (N) that forms a highly carcinogenic compound.

When Zantac interacts with stomach acid and heat in that environment, the molecule transforms into NDMA. this is the reason that people who take Zantac are showing more than 400 times the legal allowable limit of NDMA in their urine. Basically, NDMA is created during the process of digesting Zantac, which is why the Zantac cancer risk had not been discovered until recently.

Zantac contains a cancer-causing chemical (NDMA) that is up to 3,000 times greater than the FDA's daily intake level.

Contact a Zantac® Attorney with a Winning Record

Our lawyers have represented thousands against big pharmaceutical companies. If you or a loved one have been diagnosed with cancer after taking Zantac, call 1-800-587-1889  today for a free, no-obligation Zantac lawsuit evaluation.

New Orleans

Of Counsel at Huber, Thomas & Marcelle
1100 Poydras Street, Suite 2200
New Orleans, LA 70163

Phone: (504) 587-1440
Toll Free:1-800-587-1889

North Shore

Main Office and Mailing Address
2 Sanctuary Boulevard
Suite 205
Mandeville, LA 70471

Phone: (985) 605-0262
Toll Free: 1-800-587-1889

New Orleans East

New Orleans East Office
8816 Chef Menteur Highway
Suite B
New Orleans, LA 70127

Phone: (504) 587-1440
Toll Free: 1-800-587-1889

Free Case Evaluation

Copyright © 2020 The Olinde Firm - New Orleans Attorneys. All rights reserved. Disclaimer The information contained in this website may be considered advertising under the Rules of the Supreme Judicial Court of Louisiana and is for general information purposes only. Nothing contained within this or associated pages, documents, emails, or other communications should be taken as legal advice for any individual case or situation. The information on this website is not intended to create, and communications exchanged in connection with this website are not intended to create or constitute an attorney-client relationship. Although all communications are considered confidential, we do not accept representation of clients until such time as we enter into a written agreement for such representation.